ACCENT MICROCELL LIMITED vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of ACCENT MICROCELL LIMITED (ACCENTMIC) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

ACCENT MICROCELL LIMITED and SUN PHARMACEUTICAL IND L are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

37.26
P/E ratio
40.40
4.29
P/B ratio
5.57
0.20%
Dividend yield
0.83%
₹13.78
EPS
₹47.84

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

18.60%
Return on equity
16.00%
24.00%
Return on capital
21.00%
16.00%
EBITDA margin
30.00%
12.45%
Net margin
19.69%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

52.46%
Revenue CAGR (3Y)
10.03%
94.08%
Profit CAGR (3Y)
10.57%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹4.64L Cr
₹265 Cr
Revenue
₹58,462 Cr
₹33 Cr
Net profit
₹11,509 Cr
0.00
Debt / equity
0.06
ACCENT MICROCELL LIMITED
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has delivered good profit growth of 54.3% CAGR over last 5 years"]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
ACCENT MICROCELL LIMITED full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ACCENT MICROCELL LIMITED vs SUN PHARMACEUTICAL IND L: Share Price, Valuation & Which to Buy | DocStoX